RECOVERY Numbing
- Product NDC
- 76348-980
- 11-digit product format
- 763480980
- Labeler code
- 76348
- Product ID
- 76348-980_36eb74ef-8d4f-be0a-e063-6394a90a6552
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lidocaine HCl
- Dosage form
- SPRAY
- Route
- TOPICAL
- Labeler
- Renu Laboratories, LLC
- Application
- M015
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-08-01
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 5.9 g/118mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 76348-980-04 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 76348-980-04 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 76348-980-04 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 76348-980-04 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 76348-980-04 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 76348-980-04 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 76348-980-04 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 76348-980-04 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 76348-980-04 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 76348-980-04 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 76348-980-04 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 76348-980-04 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 76348-980-04 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RECOVERY Numbing
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 5.9 g/118mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1545290 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e4e05cae-56a6-b2b3-e053-2a95a90a104b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76348-980-04 | 2025-06-06 | C162847 | 48780-1 | 1030e365-484a-111a-e063-dadaa90a10e2 | RECOVERY NUMBING SPRAY |
| 76348-980-04 | 2024-01-30 | C162847 | 48780-1 | 1030e365-484a-111a-e063-dadaa90a10e2 | RECOVERY NUMBING SPRAY |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76348-980-04 | RECOVERY Numbing | 118 mL in 1 BOTTLE, SPRAY | SPRAY | 118 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GoodSense Hemorrhoidal Pain Relief | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Perrigo Direct, Inc | 2e5f699d-45e8-6451-e063-6394a90a8ad8 | 2025-07-20 | Warnings | M015 |
| Good Sense Hemorrhoidal | COCOA BUTTER, PHENYLEPHRINE HCL | L. Perrigo Company | 379f8738-a871-4b09-abd1-c86386dfee04 | 2025-07-15 | Warnings | M015 |
| Maximum Strength Hemorrhoidal Pads | WITCH HAZEL | Walmart, Inc. | 6dd8d3d9-5109-4869-917b-9521e9ba1ed0 | 2025-07-14 | Warnings | M015 |
| Nikzon Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, AND PRAMOXINE HYDROCHLORIDE | Genomma Lab USA | 8f9a9939-2c99-489f-b597-9a51ec2684f9 | 2025-07-14 | Warnings | M015 |
| ReVIVOL-XR | PHENYLEPHRINE HYDROCHLORIDE | Unipack LLC | 2950fe83-a2a4-4ed4-b645-69d6fd2381ae | 2025-07-13 | Warnings | M015 |
| medicated wipes | WITCH HAZEL | Meijer Distribution Inc. | ba0f3f9a-95d1-4d8a-86d1-2c25c945118c | 2025-07-11 | Warnings | M015 |
| hemorrhoidal pads | WITCH HAZEL | Meijer Distribution Inc. | 53e39d22-a89e-4f95-8c64-abeb50f72ce7 | 2025-07-11 | Warnings | M015 |
| INVIGOR OH | LIDOCAINE | Natureplex LLC | 7c7b536d-e41a-4017-9df9-982e2e9cfe4e | 2025-07-10 | Warnings | M015 |
| Maximum Strength Hemorrhoidal Cream with Aloe | GLYCERIN, PHENYLEPHINE HCI, PRAMOXINE HCI, PETROLATUM | Chain Drug Marketing Association | 396ea654-8be1-591a-e063-6294a90a11e2 | 2025-07-08 | Warnings | M015 |
| PREPARATION H SOOTHING RELIEF ANTI-ITCH | HYDROCORTISONE | Haleon US Holdings LLC | d6148d77-ef6f-4552-b5ba-43b429923f19 | 2025-07-07 | Warnings | M015 |
| Rectal Care Cream | RECTAL CARE CREAM | Allegiant Health | ce585082-ad39-4b6f-a756-0d9a81a13eb8 | 2025-07-07 | Warnings | M015 |
| Bisacodyl Laxative | BISACODYL LAXATIVE SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 35cb0386-a662-6893-e063-6294a90aa71a | 2025-07-03 | Warnings | M015 |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 38cf4e43-280b-eb96-e063-6294a90a5949 | 2025-07-02 | Warnings | M015 |
| TN Dickinsons Medicated Cooling Foam Hemorrhoidal Relief | WITCH HAZEL | Dickinson Brands Inc. | deca8ae2-53a3-4c90-aa10-45354e2cdab8 | 2025-06-27 | Warnings | M015 |
| Glycerin Laxative | GLYCERIN LAXATIVE SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 35cc266a-196f-16ce-e063-6394a90a24af | 2025-06-20 | Warnings | M015 |
| Phenylephrine Hemorrhoidal | HEMORRHOIDAL SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 35ccb320-e902-3d1a-e063-6294a90a68d5 | 2025-06-20 | Warnings | M015 |
| ProCure Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Twin Med LLC | 37a4cc43-0d53-f1bf-e063-6394a90a2dc9 | 2025-06-15 | Warnings | M015 |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF OINTMENT | Neilmed Pharmaceuticals Inc. | 374d89b6-9305-9adf-e063-6394a90adb32 | 2025-06-11 | Warnings | M015 |
| Dermoplast Post Partum | BENZOCAINE | Advantice Health, LLC | 374dced3-6527-b458-e063-6394a90a911e | 2025-06-11 | Warnings | M015 |
| foster and thrive hemorrhoidal | COCOA BUTTER, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | fb3bc359-b06b-4995-aa68-0117a639dff2 | 2025-06-11 | Warnings | M015 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1545290 | lidocaine HCl 5 % Topical Spray | PSN | e4e05cae-56a6-b2b3-e053-2a95a90a104b | 2 |
| 1545290 | lidocaine hydrochloride 50 MG/ML Topical Spray | SCD | e4e05cae-56a6-b2b3-e053-2a95a90a104b | 2 |
| 1545290 | lidocaine hydrochloride 5 % Topical Spray | SY | e4e05cae-56a6-b2b3-e053-2a95a90a104b | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 76348-980-04 | 76348098004 | 118 mL in 1 BOTTLE, SPRAY (76348-980-04) | 118 ml | 2022-08-01 | 0000-00-00 | No | No | Current |